[HTML] frontiersin.org

[HTML][HTML] Genomic landscape of lung adenocarcinomas in different races

H Shi, K Seegobin, F Heng, K Zhou, R Chen… - Frontiers in …, 2022 - frontiersin.org
Background: Lung adenocarcinoma is a molecularly heterogeneous disease. Several
studies, including The Cancer Genome Atlas Research Network (TCGA) and Lung Cancer …
被引用次数：14 相关文章
[HTML] nih.gov

[HTML][HTML] Genomic landscape of lung adenocarcinomas in different races

H Shi, K Seegobin, F Heng, K Zhou, R Chen… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Background Lung adenocarcinoma is a molecularly heterogeneous disease. Several
studies, including The Cancer Genome Atlas Research Network (TCGA) and Lung Cancer …

Genomic landscape of lung adenocarcinomas in different races

H Shi, K Seegobin, F Heng, K Zhou… - Frontiers in …, 2022 - mayoclinic.elsevierpure.com
Background: Lung adenocarcinoma is a molecularly heterogeneous disease. Several
studies, including The Cancer Genome Atlas Research Network (TCGA) and Lung Cancer …

Genomic landscape of lung adenocarcinomas in different races

H Shi, K Seegobin, F Heng, K Zhou… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Lung adenocarcinoma is a molecularly heterogeneous disease. Several
studies, including The Cancer Genome Atlas Research Network (TCGA) and Lung Cancer …

Genomic landscape of lung adenocarcinomas in different races

H Shi, K Seegobin, F Heng, K Zhou, R Chen… - Frontiers in …, 2022 - europepmc.org
Background Lung adenocarcinoma is a molecularly heterogeneous disease. Several
studies, including The Cancer Genome Atlas Research Network (TCGA) and Lung Cancer …

Genomic landscape of lung adenocarcinomas in different races

H Shi, K Seegobin, F Heng, K Zhou… - Frontiers in …, 2022 - digitalcommons.unf.edu
BACKGROUND: Lung adenocarcinoma is a molecularly heterogeneous disease. Several
studies, including The Cancer Genome Atlas Research Network (TCGA) and Lung Cancer …

Genomic landscape of lung adenocarcinomas in different races.

H Shi, K Seegobin, F Heng, K Zhou, R Chen… - Frontiers in …, 2022 - europepmc.org
Background Lung adenocarcinoma is a molecularly heterogeneous disease. Several
studies, including The Cancer Genome Atlas Research Network (TCGA) and Lung Cancer …